Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
- 1 November 2012
- journal article
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 130 (Supplement), S69-S76
- https://doi.org/10.1542/peds.2012-0900d
Abstract
OBJECTIVES The goal of this study was to examine rates of psychotropic medication use and identify associated child and family characteristics among children and adolescents with autism spectrum disorder (ASD) enrolled in an autism registry maintained by the Autism Treatment Network (ATN). METHODS The sample, derived from the ATN registry, consists of 2853 children aged 2 to 17 years with diagnoses of ASD supported by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the Autism Diagnostic Observation Schedule with available data on medication use. As part of initial enrollment in the registry, parents completed questionnaires on current psychotropic medication use, psychiatric and medical conditions, and demographics. RESULTS Of the 2853 children, 763 (27%) were taking ≥1 psychotropic medication; 15% were prescribed 1 medication, 7.4% received 2 medications, and 4.5% received ≥3. Among children aged 3 to 5 years, 11% were taking ≥1 psychotropic medication; among 6- to 11-year-old children, 46%; and 66% of adolescents aged 12 to 17 years were taking at ≥1 psychotropic medication. A parent report of comorbid diagnosis of attention-deficit/hyperactivity disorder, bipolar disorder, obsessive-compulsive disorder, depression, or anxiety was associated with a high rate of use, with 80% receiving ≥1 psychotropic medication. Only 15% of children with no comorbid psychiatric disorder were taking psychotropic medication. Psychotropic medication use was also related to sleep and gastrointestinal problems. CONCLUSIONS The prescription of psychotropic medications in this registry sample is highly related to comorbid psychiatric disorder. Other factors associated with use include medical comorbidities, race, ethnicity, and older age.Keywords
This publication has 28 references indexed in Scilit:
- National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007Journal of the American Academy of Child & Adolescent Psychiatry, 2010
- A Role for REM Sleep in Recalibrating the Sensitivity of the Human Brain to Specific EmotionsCerebral Cortex, 2010
- For What Diagnoses Are Psychotropic Medications Being Prescribed?CNS Drugs, 2010
- Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus ReportPublished by American Academy of Pediatrics (AAP) ,2010
- National Patterns in the Outpatient Pharmacological Management of Children and Adolescents With Autism Spectrum DisorderJournal of Clinical Psychopharmacology, 2009
- Treatment of Inattention, Overactivity, and Impulsiveness in Autism Spectrum DisordersChild and Adolescent Psychiatric Clinics of North America, 2008
- Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum DisordersPEDIATRICS, 2008
- Medication Use Among Children with Autism Spectrum DisordersJournal of Child and Adolescent Psychopharmacology, 2007
- Risperidone Treatment of Autistic Disorder: Longer-Term Benefits and Blinded Discontinuation After 6 MonthsAmerican Journal of Psychiatry, 2005
- Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North CarolinaJournal of Child and Adolescent Psychopharmacology, 2002